Cargando…

Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer

Liquid biopsy may assist in the management of cancer patients, which can be particularly applicable in pancreatic ductal adenocarcinoma (PDAC). In this study, we investigated the utility of circulating cell-free DNA (cfDNA)-based markers as prognostic tools in metastatic PDAC. Plasma was obtained fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toledano-Fonseca, Marta, Cano, M. Teresa, Inga, Elizabeth, Rodríguez-Alonso, Rosa, Gómez-España, M. Auxiliadora, Guil-Luna, Silvia, Mena-Osuna, Rafael, de la Haba-Rodríguez, Juan R., Rodríguez-Ariza, Antonio, Aranda, Enrique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409337/ https://www.ncbi.nlm.nih.gov/pubmed/32630266 http://dx.doi.org/10.3390/cancers12071754

Ejemplares similares

The Combination of Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer
por: Toledano-Fonseca, Marta, et al.
Publicado: (2021)

Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer
por: García-Ortiz, María Victoria, et al.
Publicado: (2023)

Basal VEGF-A and ACE Plasma Levels of Metastatic Colorectal Cancer Patients Have Prognostic Value for First-Line Treatment with Chemotherapy Plus Bevacizumab
por: Ortiz-Morales, M. José, et al.
Publicado: (2022)

SWATH‐based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumours
por: López‐Sánchez, Laura M., et al.
Publicado: (2019)

Association of Tumor Budding With Immune Evasion Pathways in Primary Colorectal Cancer and Patient-Derived Xenografts
por: Guil-Luna, Silvia, et al.
Publicado: (2020)

Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples
por: Vivancos, Ana, et al.
Publicado: (2019)

Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects
por: García-Ortiz, María Victoria, et al.
Publicado: (2023)

A role for endothelial nitric oxide synthase in intestinal stem cell proliferation and mesenchymal colorectal cancer
por: Peñarando, Jon, et al.
Publicado: (2018)

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
por: Dathathri, Eshwari, et al.
Publicado: (2022)

Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
por: Patelli, Giorgio, et al.
Publicado: (2021)

KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors
por: Morales-Estevez, Cristina, et al.
Publicado: (2016)

The Metastatic Cascade as the Basis for Liquid Biopsy Development
por: Eslami-S, Zahra, et al.
Publicado: (2020)

The addition of celecoxib improves the antitumor effect of cetuximab in colorectal cancer: role of EGFR-RAS-FOXM1-β-catenin signaling axis
por: Valverde, Araceli, et al.
Publicado: (2017)

Liquid Biopsy in Diagnosis and Prognosis of Non-Metastatic Prostate Cancer
por: Rzhevskiy, Alexey S., et al.
Publicado: (2022)

Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes
por: Manzanares-Martin, Barbara, et al.
Publicado: (2021)

Liquid biopsy in metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019)

Circulating Cell-Free DNA in Liquid Biopsies as Potential Biomarker for Bladder Cancer: A Systematic Review
por: Herranz, Raquel, et al.
Publicado: (2021)

Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients
por: de Miguel Pérez, Diego, et al.
Publicado: (2020)

Circulating tumor cells and DNA as liquid biopsies
por: Heitzer, Ellen, et al.
Publicado: (2013)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
por: Polasik, Arkadius, et al.
Publicado: (2017)

Single cell correlation analysis of liquid and solid biopsies in metastatic colorectal cancer
por: Gerdtsson, Anna S., et al.
Publicado: (2019)

Circulating platelets as liquid biopsy sources for cancer detection
por: Antunes‐Ferreira, Mafalda, et al.
Publicado: (2020)

Defining A Liquid Biopsy Profile of Circulating Tumor Cells and Oncosomes in Metastatic Colorectal Cancer for Clinical Utility
por: Narayan, Sachin, et al.
Publicado: (2022)

Circulating noncoding RNAs: promising biomarkers in liquid biopsy for the diagnosis, prognosis, and therapy of NSCLC
por: Li, Yilin, et al.
Publicado: (2023)

Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer
por: Gao, Wei, et al.
Publicado: (2021)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers
por: Yin, Chang-Qing, et al.
Publicado: (2016)

Recent Advances in Liquid Biopsy Based on Circulating Tumor DNA
por: Sakuma, Yu, et al.
Publicado: (2019)

Circulating microRNAs: Challenges with their use as liquid biopsy biomarkers
por: Takizawa, Satoko, et al.
Publicado: (2022)

Laser transfer for circulating tumor cell isolation in liquid biopsy
por: Molpeceres, Carlos, et al.
Publicado: (2023)

Liquid Biopsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring
por: Shaik, Mohammed Rifat, et al.
Publicado: (2023)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
por: Cheng, Xianliang, et al.
Publicado: (2017)

Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer
por: Rodriguez-Casanova, Aitor, et al.
Publicado: (2021)

The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma
por: Fattore, Luigi, et al.
Publicado: (2021)

Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer
por: Taniguchi, Fumitaka, et al.
Publicado: (2021)

Liquid Biopsy in Pancreatic Cancer: Are We Ready to Apply It in the Clinical Practice?
por: Heredia-Soto, Victoria, et al.
Publicado: (2021)

Simultaneous Inhibition of EGFR/VEGFR and Cyclooxygenase-2 Targets Stemness-Related Pathways in Colorectal Cancer Cells
por: Valverde, Araceli, et al.
Publicado: (2015)

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
por: Cheng, Feifei, et al.
Publicado: (2016)

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
por: Larrea, Erika, et al.
Publicado: (2016)

Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer
por: Grunvald, Miles W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bqmi6397c2ki06uas3lmnnlbj9